From the Journals

Squamous cell carcinoma linked to 25% increase in all-cause mortality


 

FROM JAAD


Squamous cell carcinomas (SCC), but not basal cell carcinomas (BCC), were associated with a risk of death from any cause that was 25% higher than that seen in the general population, based on a systematic literature review and meta-analysis published in the Journal of American Academy of Dermatology (2017. doi: 10.1016/j.jaad.2017.11.026).


“Because these tumors often occur in the same patients and are both often caused by exposure to ultraviolet radiation, patients with BCC and SCC are often grouped together,” Mackenzie R. Wehner, MD, of the University of Pennsylvania, Philadelphia, and co-authors wrote. “Our data contributes to the argument that the carcinogenesis of these tumors and long-term outcomes for patients with these tumors may be distinct.”


Patients with SCC “may need additional education and age-appropriate screening to prevent deaths from major diseases,” the authors concluded.
Dr. Wehner and colleagues systematically searched the medical literature and found four studies encompassing a total of 175,849 patients with SCC and 464,230 patients with BCC.

Kelly Nelson/National Cancer Institute/Wikimedia Commons

Squamous cell carcinoma


Relative to the general population, mortality for those with an SCC was 1.25 (95% CI, 1.17-1.32). At 0.92 (95% CI 0.83-1.02), there was no significant difference in mortality for patients with a BCC.


Collectively and individually, the studies found a statistically significant increased relative mortality for having SCC.
There are clear distinctions between BCC and SCC with regard to histology, pathophysiology, survival, and other parameters, the study authors said. “While many patients get both BCC and SCC, future research should take into account that these cancers may have different long-term risks and outcomes.”

Recommended Reading

Merkel cell carcinoma most likely to recur within 2 years of diagnosis
MDedge Hematology and Oncology
Tattoo artist survey finds almost half agree to tattoo skin with lesions
MDedge Hematology and Oncology
Chronic GVHD linked to fivefold increase in squamous cell skin carcinomas
MDedge Hematology and Oncology
Study links photosensitizing antihypertensives to SCC
MDedge Hematology and Oncology
Skin cancer risk similar for liver and kidney transplant recipients
MDedge Hematology and Oncology
Mupirocin plus chlorhexidine halved Mohs surgical-site infections
MDedge Hematology and Oncology
Skin cancer procedures up by 35% since 2012
MDedge Hematology and Oncology
Subsequent squamous cell carcinoma risk higher in HIV patients with low CD4 count
MDedge Hematology and Oncology
Ibrutinib and bleeding complications in Mohs surgery
MDedge Hematology and Oncology
Diagnosing high-risk keratinocyte carcinomas in the dermatology clinic
MDedge Hematology and Oncology